Surgery in high-grade insular tumors: Oncological and seizure outcomes from 41 consecutive patients

Background: Insular high-grade gliomas are uncommon and constitute approximately 10% of all intracranial high-grade gliomas. Several publications in the recent years have thrown substantial light in the understanding of insular low-grade gliomas. However, there is a paucity of information concerning the spectrum of high-grade lesions affecting the insula, the mode of presentation vis-à -vis low-grade gliomas, and the survival rates to modern therapy. Aims and Objectives: We aim to highlight various clinical patterns, histo-pathological spectrum and the survival rates in patients with high-grade insular lesions. Also, we explore the factors that govern favourable outcomes. Materials and Methods: A retrospective study of 41 patients operated for high-grade insular tumors at our institute between March 2010 to December 2018 was done to evaluate the clinico-radiological features, surgical nuances, survival rates and seizure outcomes. Results: Raised intracranial pressure was the most frequent clinical presentation (n=28/41, 68.3%). Nearly 60% of the patients (n=25) had involvement of all four Berger-Sanai zones. The high-grade tumors encountered in our series were: glioblastoma (n=15), gliosarcoma (n=3), and embryonal tumor, not otherwise specified in 3 patients, while 21 patients had grade 3 astrocytoma. 33 out of 41 patients (80.5%) in our study showed excellent seizure control (ILAE grade 1A) at follow-up. Clinical presentation with seizures (P = 0.01, HR=0.3), WHO grade IV histopathology (P = 0.04, HR=3.7) and development of recurrence (P = 0.05, HR=5.5) were found to be independent predictors of OS. Conclusion: Insular high-grade gliomas are commoner than thought and nearly half of these are grade IV tumors (51%). A presentation with seizures may indicate precursor low-grade gliomas and portend a better survival. A maximum “safe” surgical resection, keeping the postoperative quality of life in mind, should be the goal.

Key-words:

Factors - glioblastoma - high-grade glioma - insular lobe - outcome - surgery - survival

Financial support and sponsorship

Nil.

Publikationsverlauf

Eingereicht: 15. Januar 2020

Angenommen: 05. April 2020

Artikel online veröffentlicht:
16. August 2022

• References

• 1 Lang FF, Olansen NE, DeMonte F, Gokaslan ZL, Holland EC, Kalhorn C, et al. Surgical resection of intrinsic insular tumors: Complication avoidance. J Neurosurg 2001;95:638-50.
• 2 Das KK, Singh S, Deora H, Khatri D, Mehrotra A, Srivastava AK, et al. Microsurgical excision of giant dominant lobe insular cavernoma presenting acutely: Sometimes you win, sometimes you learn. Interdiscip Neurosurg Adv Tech Case Manag 2019;18:100475.
• 3 Duffau H. Surgery of insular gliomas. Prog Neurol Surg 2018;30:173-85.
• 4 Deora H, Das KK, Jaiswal A, Behari S. Letter to the Editor. Tumor extension determines approach in insular gliomas. J Neurosurg 2019:1-2. [doi: 10.3171/2019.5.JNS191308].
• 5 Brown TJ, Brennan MC, Li M, Church EW, Brandmeir NJ, Rakszawski KL, et al. Association of the extent of resection with survival in glioblastoma: A systematic review and meta-analysis. JAMA Oncol 2016;2:1460-9.
• 6 Khan I, Waqas M, Shamim MS. Role of intra-operative MRI (iMRI) in improving extent of resection and survival in patients with glioblastoma multiforme. J Pak Med Assoc 2017;67:1121-3.
• 7 Li YM, Suki D, Hess K, Sawaya R. The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection? J Neurosurg 2016;124:977-88.
• 8 Duffau H, Capelle L. Preferential brain locations of low-grade gliomas. Cancer 2004;100:2622-6.
• 9 Zhou C, Wang Y, Liu X, Liang Y, Fan Z, Jiang T, et al. Molecular profiles for insular low-grade gliomas with putamen involvement. J Neurooncol 2018;138:659-66.
• 10 Tang C, Zhang ZY, Chen LC, Sun Z, Zhang Y, Qin Z, et al. Subgroup characteristics of insular low-grade glioma based on clinical and molecular analysis of 42 cases. J Neurooncol 2016;126:499-507.
• 11 Velasquez C, Caballero H, Vazquez-Barquero A, Vega M, Rial JC, Carcedo-Barrio MC, et al. Insular gliomas with exophytic extension to the sylvian cistern: A glioma growth pattern that has gone previously unnoticed. World Neurosurg 2016;87:200-6.
• 12 Sanai N, Polley MY, Berger MS. Insular glioma resection: assessment of patient morbidity, survival, and tumor progression. J Neurosurg 2010;112:1-9.
• 13 Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987-96.
• 14 Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, et al. The 2016 World Health Organization classification of tumors of the central nervous system: A summary. Acta Neuropathol 2016;131:803-20.
• 15 Durnford AJ, Rodgers W, Kirkham FJ, Mullee MA, Whitney A, Prevett M, et al. Very good inter-rater reliability of engel and ILAE epilepsy surgery outcome classifications in a series of 76 patients. Seizure 2011;20:809-12.
• 16 Panigrahi M, Chandrasekhar YB, Vooturi S, Ram GA, Rammohan VS. Surgical resection of insular gliomas and roles of functional magnetic resonance imaging and diffusion tensor imaging tractography-single surgeon experience. World Neurosurg 2017;98:587-93.
• 17 Eseonu CI, ReFaey K, Garcia O, Raghuraman G, Quinones-Hinojosa A. Volumetric analysis of extent of resection, survival, and surgical outcomes for insular gliomas. World Neurosurg 2017;103:265-74.
• 18 Wang Y, Wang Y, Fan X, Li S, Liu X, Wang J, et al. Putamen involvement and survival outcomes in patients with insular low-grade gliomas. J Neurosurg 2017;126:1788-94.
• 19 Moshel YA, Marcus JD, Parker EC, Kelly PJ. Resection of insular gliomas: The importance of lenticulostriate artery position. J Neurosurg 2008;109:825-34.
• 20 Yaşargil MG, von Ammon K, Cavazos E, Doczi T, Reeves JD, Roth P. Tumours of the limbic and paralimbic systems. Acta Neurochir (Wien) 1992;118:40-52.
• 21 Hervey-Jumper SL, Berger MS. Insular glioma surgery: An evolution of thought and practice. J Neurosurg 2019;130:9-16.
• 22 Khatri D, Jaiswal A, Das KK, Pandey S, Bhaisora K, Kumar R. Health-related quality of life after surgery in supratentorial gliomas. Neurol India 2019;67:467-75.
• 23 Sanai N, Polley MY, McDermott MW, Parsa AT, Berger MS. An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg 2011;115:3-8.
• 24 Grabowski MM, Recinos PF, Nowacki AS, Schroeder JL, Angelov L, Barnett GH, et al. Residual tumor volume versus extent of resection: Predictors of survival after surgery for glioblastoma. J Neurosurg 2014;121:1115-23.
• 25 Xing Y, Wang X. Which parameter is more important for the prognosis of new-onset adult glioblastoma: Residual tumor volume or extent of resection? World Neurosurg 2018;116:e444-51.
• 26 Chaichana KL, Cabrera-Aldana EE, Jusue-Torres I, Wijesekera O, Olivi A, Rahman M, et al. When gross total resection of a glioblastoma is possible, how much resection should be achieved? World Neurosurg 2014;82:e257-65.
• 27 Michaud K, Duffau H. Surgery of insular and paralimbic diffuse low-grade gliomas: Technical considerations. J Neurooncol 2016;130:289-98.